Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.

UnityPoint is expanding its specialty care services by opening three new clinics, including plastic surgery, in the Waukee ...

We came across a bullish thesis on United Therapeutics Corporation on BioEquity Watch’s Substack. In this article, we will ...

Tuberculosis has plagued humanity for thousands of years, and despite medical advances that can now help us prevent and cure ...

Global Heparin Market OverviewThe global heparin market is projected to expand at a steady compound annual growth rate of around 5% through 2031, supported by the rising burden of chronic and ...

Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of proprietary cell-derived therapies for fibrotic diseases, today announces the initiation of "a partially-blinded ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Labcorp , a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help clinicians ...

Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...

Finally, he has been involved in training generations of extraordinary scientists—the Corey school—who are further shaping ...